BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11493377)

  • 1. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation.
    Hoang MP; Prieto VG; Burchette JL; Shea CR
    J Cutan Pathol; 2001 Sep; 28(8):400-6. PubMed ID: 11493377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma with paradoxical maturation.
    Ruhoy SM; Prieto VG; Eliason SL; Grichnik JM; Burchette JL; Shea CR
    Am J Surg Pathol; 2000 Dec; 24(12):1600-14. PubMed ID: 11117780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.
    Harvell JD; Bastian BC; LeBoit PE
    Am J Surg Pathol; 2002 May; 26(5):654-61. PubMed ID: 11979096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal melanocytic nevus with prominent schwannian differentiation.
    Kroumpouzos G; Cohen LM
    Am J Dermatopathol; 2002 Feb; 24(1):39-42. PubMed ID: 11803280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosinase and nestin immunohistochemical expression in melanocytic nevi as a histopathologic pattern to trace melanocyte differentiation and nevogenesis.
    Murtas D; Pilloni L; Diana A; Casula L; Tomei S; Piras F; Ferreli C; Maxia C; Perra MT
    Histochem Cell Biol; 2019 Feb; 151(2):175-185. PubMed ID: 30232588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosette formation within a proliferative nodule of an atypical combined melanocytic nevus in an adult.
    Hoang MP; Rakheja D; Amirkhan RH
    Am J Dermatopathol; 2003 Feb; 25(1):35-9. PubMed ID: 12544098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
    Sexton M; Sexton CW
    Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
    de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
    Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
    Busam KJ; Granter SR; Iversen K; Jungbluth AA
    Am J Dermatopathol; 2000 Jun; 22(3):237-41. PubMed ID: 10871066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.
    Boyle JL; Haupt HM; Stern JB; Multhaupt HA
    Arch Pathol Lab Med; 2002 Jul; 126(7):816-22. PubMed ID: 12088451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
    Lohmann CM; Iversen K; Jungbluth AA; Berwick M; Busam KJ
    Am J Surg Pathol; 2002 Oct; 26(10):1351-7. PubMed ID: 12360050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound nevus with congenital features and balloon cell changes--an immunohistochemical study.
    Cagnano E; Benharroch D; Sion-Vardy N
    Ann Diagn Pathol; 2008 Oct; 12(5):362-4. PubMed ID: 18774500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
    Clarkson KS; Sturdgess IC; Molyneux AJ
    J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypoid Compound Melanocytic Proliferations: A Clinicopathological Study.
    Mesbah Ardakani N; Harvey NT; Wood BA
    Am J Dermatopathol; 2019 Aug; 41(8):578-584. PubMed ID: 31335410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of HMB-45 in traumatized melanocytic nevi.
    Leleux TM; Prieto VG; Diwan AH
    J Am Acad Dermatol; 2012 Sep; 67(3):446-50. PubMed ID: 22285619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
    Steuhl KP; Rohrbach JM; Knorr M
    Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.